Vital Signs Monitoring Devices Market by Product, by End User - Global Opportunity Analysis and Industry Forecast, 2014-2022

  • ID: 4033359
  • Report
  • Region: Global
  • 234 pages
  • Allied Analytics LLP
1 of 5

FEATURED COMPANIES

  • A&D Company, Limited
  • Masimo Corporation
  • Medtronic plc
  • Nihon Kohden Corporation
  • Nonin Medical, Inc.
  • Omron Corporation
  • MORE

Vital Signs Monitoring Devices Market by Product (Blood Pressure Monitoring Devices, Pulse Oximeters and Temperature Monitoring Devices), by End User (Hospitals & Clinics, Ambulatory Surgery Centers, and Home Care Settings) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Vital signs monitoring devices are used for the measurement of vital parameters, including blood pressure, heart rate, respiratory rate, and body temperature, to monitor physical functioning of the body. They offer clinically relevant information regarding the health status of the patients. This information plays a vital role in identifying the presence of any acute medical problem or chronic disease state. Vital signs of a patient are recorded at the emergency department, pre- and post-surgery, and during treatment at hospitals.

The global vital signs monitoring devices market is expected to reach $5,491 million by 2022 from $3,694 million in 2015, growing at a CAGR of 5.8% during the study period. This market is expected to witness significant growth during the forecast period due to increase in importance of vital signs monitoring devices in home care settings and improved reimbursement scenario for pulse oximeters in developed countries. In addition, upsurge in geriatric population and rise in incidence rate of cardiovascular disorders such as hypertension and other preexisting health conditions including COPD, sleep apnea, and infectious diseases have fueled the demand for vital signs monitoring devices. Moreover, increase in use of vital signs monitoring devices for fitness monitoring and rise in ambulatory surgery centers that use vital signs monitoring devices routinely have fueled the market growth. However, lack of awareness about these devices in the low- and middle-income countries hamper the market growth.

The vital signs monitoring devices market is segmented on the basis of product type, end user, and geography. Based on product type, the market is segmented into blood pressure monitoring devices, pulse oximeters, and temperature monitoring. On the basis of end user, the market is classified into hospitals & clinics, ambulatory surgery centers, and home care settings. The market is analyzed on the basis of four geographical regions, which include North America, Europe, Asia-Pacific, and LAMEA.

Prominent players have adopted product development including product launches, approvals, and clinical trials as their key developmental strategy to expand their product portfolio. For instance, in July 2016, SunTech (now Halma plc) received FDA clearance for its next generation spot-check vital signs device, SunTech C40. The device helps in the accurate measurement of blood pressure plus other vital signs including temperature and pulse oximetry using advanced features and digital connectivity. Moreover, reimbursement policies for pulse oximeters have fueled the demand for vital signs monitoring products. For instance, Medicare offers reimbursement for pulse oximeters used for a pulmonary disease(s) in case of using diagnosis code ICD-9-CM, which describes a patient’s condition and the motive of using the service or procedure. The present procedural technology identifies three codes for oximetry-94760, 94761, and 94762.

Key benefits

This report provides an extensive analysis of the current and emerging market trends and dynamics in the global vital signs monitoring devices market.
Comprehensive analysis of all geographic regions is provided to determine the prevailing opportunities across the geographies.
This study evaluates the competitive landscape of the market to predict the competitive environment across geographies.
This report entails the detailed quantitative analysis of the current market and estimations from 2014 to 2022 to identify the prevailing opportunities.
Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.
Region- and country-wise vital signs monitoring devices market conditions are comprehensively analyzed in the report.

Key market segments

BY PRODUCT TYPE

Blood Pressure Monitoring Device
Aneroid BP Monitors
Digital BP Monitors
Ambulatory BP Monitors
Blood Pressure Instrument Accessories
Pulse Oximeters
Table-top/Bedside Pulse Oximeters
Fingertip Pulse Oximeters
Hand-held Pulse Oximeters
Wrist-worn Pulse Oximeters
Pediatric Pulse Oximeters
Temperature Monitoring Device
Digital Thermometers
Infrared Thermometers
Temperature Strips

By End User

Hospitals & Clinics
Ambulatory Surgery Centers (ASCs)
Home Care Settings

BY GEOGRAPHY

North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Taiwan
Indonesia
Thailand
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
Venezuela
Saudi Arabia
Republic of South Africa
Colombia
Argentina
Rest of LAMEA

READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • A&D Company, Limited
  • Masimo Corporation
  • Medtronic plc
  • Nihon Kohden Corporation
  • Nonin Medical, Inc.
  • Omron Corporation
  • MORE
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. KEY PLAYERS
1.5. RESEARCH METHODOLOGY
1.5.1. Secondary research
1.5.2. Primary research
1.5.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top winning strategies
3.2.1.1. Competitive intelligence and strategies of companies
3.2.2. Top investment pockets
3.2.3. Top player positioning
3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. Increase in geriatric population
3.3.1.2. Technological advancement
3.3.1.3. Rise in prevalence of diseases
3.3.1.4. Growing demand for portable monitoring devices

3.3.2. Restraints

3.3.2.1. Lack of awareness in developing countries
3.3.3. Opportunities
3.3.3.1. Increase in healthcare expenditure in emerging economies
3.3.3.2. Proactive monitoring

CHAPTER 4 VITAL SIGNS MONITORING DEVICES MARKET, BY PRODUCT
4.1. OVERVIEW

4.1.1. Market size and forecast
4.2. BLOOD PRESSURE (BP) MONITORING DEVICES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Aneroid BP monitors
4.2.4.1. Market size and forecast

4.2.5. Digital BP monitor
4.2.5.1. Market size and forecast

4.2.6. Blood Pressure Instrument Accessories
4.2.6.1. Market size and forecast

4.2.7. Ambulatory BP monitor
4.2.7.1. Market size and forecast

4.3. PULSE OXIMETERS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Table-top/bedside pulse oximeters
4.3.4.1. Market size and forecast

4.3.5. Fingertip pulse oximeters
4.3.5.1. Market size and forecast

4.3.6. Hand-held pulse oximeters
4.3.6.1. Market size and forecast

4.3.7. Wrist-worn pulse oximeters
4.3.7.1. Market size and forecast

4.3.8. Pediatric Pulse Oximeters
4.3.8.1. Market size and forecast

4.4. TEMPERATURE MONITORING DEVICES

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Mercury-filled thermometers
4.4.4.1. Market size and forecast

4.4.5. Digital thermometers
4.4.5.1. Market size and forecast

4.4.6. Infrared thermometers
4.4.6.1. Market size and forecast

4.4.7. Temperature strips
4.4.7.1. Market size and forecast

CHAPTER 5 VITAL SIGNS MONITORING DEVICES MARKET, BY END USER
5.1. OVERVIEW
5.1.1. Market size and forecast

5.2. HOSPITALS & CLINICS
5.2.1. Market size and forecast

5.3. AMBULATORY SURGERY CENTERS
5.3.1. Market size and forecast

5.4. HOME CARE SETTINGS
5.4.1. Market size and forecast

CHAPTER 6 VITAL SIGNS MONITORING DEVICES MARKET, BY GEOGRAPHY
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S. market size and forecast
6.2.5. Canada market size and forecast
6.2.6. Mexico market size and forecast
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany market size and forecast
6.3.5. France market size and forecast
6.3.6. U.K. market size and forecast
6.3.7. Italy market size and forecast
6.3.8. Spain market size and forecast
6.3.9. Russia market size and forecast
6.3.10. Rest of Europe market size and forecast
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan market size and forecast
6.4.5. China market size and forecast
6.4.6. Australia market size and forecast
6.4.7. India market size and forecast
6.4.8. South Korea market size and forecast
6.4.9. Taiwan market size and forecast
6.4.10. Indonesia market size and forecast
6.4.11. Thailand market size and forecast
6.4.12. Rest of Asia-Pacific market size and forecast
6.5. LAMEA
6.5.1. Blood pressure levels
6.5.2. Risks associated with high blood pressure
6.5.3. Key market trends
6.5.4. Growth factors and opportunities
6.5.5. Market size and forecast
6.5.6. Brazil market size and forecast
6.5.7. Turkey market size and forecast
6.5.8. Venezuela market size and forecast
6.5.9. Saudi Arabia market size and forecast
6.5.10. Republic of South Africa market size and forecast
6.5.11. Colombia market size and forecast
6.5.12. Argentina market size and forecast
6.5.13. Rest of LAMEA market size and forecast

CHAPTER 7 COMPANY PROFILES
7.1. HILL-ROM HOLDINGS, INC.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Business performance
7.2. HALMA PLC

7.2.1. Company overview
7.2.2. Operating business segments
7.2.3. Business performance
7.2.4. Key strategic moves and developments
7.3. NONIN MEDICAL, INC.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Key strategic moves and developments
7.4. OMRON CORPORATION
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance
7.4.5. Key strategic moves and developments

7.5. MASIMO CORPORATION
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Business performance
7.5.5. Key strategic moves and developments

7.6. GENERAL ELECTRIC COMPANY
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Business performance

7.7. MEDTRONIC PLC
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. BUSINESS PERFORMANCE
7.7.5. Key strategic moves and developments

7.8. NIHON KOHDEN CORPORATION
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Business performance
7.8.5. Key strategic moves and developments

7.9. KONINKLIJKE PHILIPS N.V.
7.9.1. Company Overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Business performance
7.9.5. Key strategic moves and developments

7.10. A&D COMPANY, LIMITED
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Business performance

7.11. CONTEC MEDICAL SYSTEM CO., LTD.
7.11.1. Company overview
7.11.2. Company snapshot
7.11.3. Operating business segments

7.12. SMITHS GROUP PLC
7.12.1. Company overview
7.12.2. Operating business segments
7.12.3. Business performance
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • A&D Company, Limited
  • Masimo Corporation
  • Medtronic plc
  • Nihon Kohden Corporation
  • Nonin Medical, Inc.
  • Omron Corporation
  • MORE
Vital signs monitoring market size was worth $3,694 million in 2015 and is expected to reach $5,491 million by 2022, growing at a CAGR of 5.8% from 2016 to 2022. North America was the leading regional market in global vital signs monitoring devices industry. The blood pressure monitoring devices segment is expected to maintain its lead throughout the forecast period.

Factors such asincrease in geriatric population, growth of inclination towards home monitoring, and rise in incidence rate of chronic diseases, such as cardiovascular disorders and obesity, are expected to drive the growth of the market. Moreover, introduction of innovative and technologically advanced digital blood pressure monitors and finger pulse oximeters is set to further drive the market growth. However, lack of awareness about these devices in low- and middle-income economies hampers the market growth.

Among the vital signs monitoring devices, BP monitoring devicesis anticipated to uphold the dominating position in the global market in the upcoming years, owing to increase in incidences of obesity, hypertension, diabetes, and other lifestyle disorders. Pulse oximetry devices are projected to be the fastest growing segment, with CAGR of 6.3%, due to increase in incidences of respiratory disorders (such as COPD) across the globe.

In the end-user segment, hospitals & clinics occupied the major share of the vital signs monitoring devices market, as these devices facilitate early detection of a patients deteriorating health condition; thereby, enabling speedy intervention and diagnosis of the disease. Home environmentswas the other dominant end-user segment, expected to grow at a CAGR of 6.1%.

Key Findings of the Vital Signs Monitoring Devices Market:
Based on product type, BP monitoring devices segment accounted for more than half of the total market in 2015.
Digital BP monitors segment accounted for more than one-third share of the BP monitoring devices market; while ambulatory BPmonitorsis expected to grow at the highest CAGR of 7.5% during the forecast period.
Amongst the pulse oximeters devices, fingertip pulse oximeters are expected to grow at a high rate as they can be easily used in home environments and do not require trained professionalforoperation of the device.
Digital thermometers accounted formajor chunk of the temperature monitoring devices market in 2015; while infrared thermometers segment is poised to grow at the highest CAGR of 5.7% during the forecast period.
Asia-Pacific is expected to bethefastest growing region throughout the analysis period, owing to presence of ample growth opportunities in terms of unmet medical needs for the treatment of cardiovascular disorders in this region and high disposable income of the population.
Germany and France jointly accounted for almost one-third of the European vital signs monitoring devices market in 2015.
North America generated the highest revenue, accounting forapproximately two-fifth share of the overall vital signs monitoring devices market in 2015, and is expected to maintain this trend throughout the forecast period. This is attributed to the rise in the prevalence of respiratory disorders, growth in awareness among patients regarding cost-effective vital signs monitoring devices, and availability of advanced healthcare facilities in the North American countries.

The key players profiled in this report include Welch Allyn (a subsidiary of Hill-Rom Holdings, Inc.), SunTech Medical Inc. (a subsidiary of Halma plc), Nonin Medical, Inc., Omron Corporation, Masimo Corporation, General Electric Company, Medtronic plc, Nihon Kohden Corporation, Koninklijke Philips N.V., and A&D Company, Limited.
Note: Product cover images may vary from those shown
5 of 5
  • Welch Allyn (a subsidiary of Hill-Rom Holdings, Inc.)
  • SunTech Medical, Inc. (a subsidiary of Halma plc)
  • Nonin Medical, Inc.
  • Omron Corporation
  • Masimo Corporation
  • Contec Medical Systems Co., Ltd
  • Medtronic plc
  • Nihon Kohden Corporation
  • Smiths Group plc
  • A&D Company, Limited
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll